Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q2 2024 Earnings

8MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.91

-0.85

-0.78

-0.72

Details

Expected EPS

-0.85

Actual EPS

-0.72

Surprise EPS

0.13

Surprise Percent

+15.29%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.72 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.